Company / Working Capital
ABEONA THERAPEUTICS INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$175.3M
FY2025
5-year range
$38.8M / $175.3M
FY2021-FY2025
Trend
+108.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from $39M in FY2021 to $175M in FY2025.
Based on SEC 10-K filings.
$175M in FY2025 with a 5-year CAGR of +25.7%.
Improved from $42M to $175M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +57.0%
- 5-Year CAGR
- +25.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +25.7%, indicating consistent growth.
- In FY2025, working capital increased 108.1% year-over-year.
- Lowest working capital in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $175.3M | +108.1% |
| FY2024 | $84.3M | +99.1% |
| FY2023 | $42.3M | -6.6% |
| FY2022 | $45.3M | +16.9% |
| FY2021 | $38.8M | -30.5% |
| FY2020 | $55.8M | -40.5% |
| FY2019 | $93.7M | +36.8% |
| FY2018 | $68.5M | -49.3% |
| FY2017 | $135.0M | +120.8% |
| FY2016 | $61.1M | +56.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026